Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 2
2003 1
2004 4
2005 2
2006 3
2007 2
2008 4
2009 3
2010 4
2011 4
2012 5
2013 2
2014 1
2015 1
2016 2
2017 3
2018 2
2019 2
2020 1
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Type I interferon-related kidney disorders.
Lodi L, Mastrolia MV, Bello F, Rossi GM, Angelotti ML, Crow YJ, Romagnani P, Vaglio A. Lodi L, et al. Kidney Int. 2022 Jun;101(6):1142-1159. doi: 10.1016/j.kint.2022.02.031. Epub 2022 Mar 24. Kidney Int. 2022. PMID: 35339535 Review.
All these IFN-I-related disorders can cause renal dysfunction and share pathogenic and histopathological features. Collapsing glomerulopathy, a histopathological lesion characterized by podocyte loss, collapse of the vascular tuft, and parietal epithelial cell proli …
All these IFN-I-related disorders can cause renal dysfunction and share pathogenic and histopathological features. Collapsing glom …
Clofarabine-induced kidney toxicity.
Jhaveri KD, Chidella S, Allen SL, Fishbane S. Jhaveri KD, et al. J Oncol Pharm Pract. 2014 Aug;20(4):305-8. doi: 10.1177/1078155213504976. Epub 2013 Sep 29. J Oncol Pharm Pract. 2014. PMID: 24081220
Since clofarabine inhibits ribonucleotide reductase, we postulate by extrapolation from the animal studies that collapsing glomerulopathy or severe tubular injury or a combination of both may be the mechanism of acute kidney injury observed with this agent. ...
Since clofarabine inhibits ribonucleotide reductase, we postulate by extrapolation from the animal studies that collapsing glomeru …
Parvovirus-B19-associated complications in renal transplant recipients.
Waldman M, Kopp JB. Waldman M, et al. Nat Clin Pract Nephrol. 2007 Oct;3(10):540-50. doi: 10.1038/ncpneph0609. Nat Clin Pract Nephrol. 2007. PMID: 17895931 Review.
Thus, this diagnosis should be considered in transplant recipients with unexplained anemia and reticulocytopenia or pancytopenia. Collapsing glomerulopathy and thrombotic microangiopathy have been reported in association with B19 infection in renal transplant recipi …
Thus, this diagnosis should be considered in transplant recipients with unexplained anemia and reticulocytopenia or pancytopenia. Collaps …
Podocytopathies related to either COVID-19 infection or its vaccination, our experience and literature review.
Pokharel A, Anderson JD, Deebajah M, Blatt NB, Reddy G, Garlapaty V, Li W, Kanaan HD, Zhang PL. Pokharel A, et al. Ultrastruct Pathol. 2023 Sep 3;47(5):373-381. doi: 10.1080/01913123.2023.2237565. Epub 2023 Jul 18. Ultrastruct Pathol. 2023. PMID: 37463165 Review.
In addition, from the middle period to the near end of the COVID-19 pandemic, we have seen two of the patients who developed nephrotic syndrome following COVID-19 vaccination. Three of 4 podocytopathies were collapsing glomerulopathy (also called collapsing focal se …
In addition, from the middle period to the near end of the COVID-19 pandemic, we have seen two of the patients who developed nephrotic syndr …
Collapsing glomerulopathy following anthracycline therapy.
Mohamed N, Goldstein J, Schiff J, John R. Mohamed N, et al. Am J Kidney Dis. 2013 May;61(5):778-81. doi: 10.1053/j.ajkd.2012.08.048. Epub 2012 Dec 6. Am J Kidney Dis. 2013. PMID: 23219112
We report 2 cases of anthracycline-induced collapsing glomerulopathy, one in a patient treated for peripheral T-cell lymphoma, and the other in a kidney transplant recipient treated for acute myeloid leukemia. Collapsing glomerulopathy is a distinct va …
We report 2 cases of anthracycline-induced collapsing glomerulopathy, one in a patient treated for peripheral T-cell lymphoma, …
The association between adult-onset Still's disease and collapsing glomerulopathy: a case report.
Orentas M, Patel N, Rodby R, Hassan S. Orentas M, et al. J Med Case Rep. 2022 Oct 14;16(1):370. doi: 10.1186/s13256-022-03606-1. J Med Case Rep. 2022. PMID: 36229843 Free PMC article. Review.
Among the many causes of collapsing glomerulopathy, autoimmune diseases, such as systemic lupus erythematosus, have been implicated. ...Her collapsing glomerulopathy was initially well controlled following induction therapy with cyclosporine and predni …
Among the many causes of collapsing glomerulopathy, autoimmune diseases, such as systemic lupus erythematosus, have been impli …
Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy.
Duret LC, Hamidouche T, Steers NJ, Pons C, Soubeiran N, Buret D, Gilson E, Gharavi AG, D'Agati VD, Shkreli M. Duret LC, et al. Kidney Int. 2024 May;105(5):980-996. doi: 10.1016/j.kint.2024.02.009. Epub 2024 Feb 27. Kidney Int. 2024. PMID: 38423182 Free article.
Collapsing focal segmental glomerulosclerosis (FSGS), also known as collapsing glomerulopathy (CG), is the most aggressive variant of FSGS and is characterized by a rapid progression to kidney failure. ...
Collapsing focal segmental glomerulosclerosis (FSGS), also known as collapsing glomerulopathy (CG), is the most aggressive var …
Idiopathic collapsing glomerulopathy in children.
Gulati A, Sharma A, Hari P, Dinda AK, Bagga A. Gulati A, et al. Clin Exp Nephrol. 2008 Oct;12(5):348-353. doi: 10.1007/s10157-008-0053-6. Epub 2008 Apr 8. Clin Exp Nephrol. 2008. PMID: 18392736
BACKGROUND: Collapsing glomerulopathy (CG) is a clinically and pathologically distinct variant of focal segmental glomerulosclerosis (FSGS). ...Two of the six patients progressed to end-stage renal disease within a median follow-up period of 27 months (range 14-96 m …
BACKGROUND: Collapsing glomerulopathy (CG) is a clinically and pathologically distinct variant of focal segmental glomeruloscl …
Monoclonal antibodies for podocytopathies: rationale and clinical responses.
Marasà M, Kopp JB. Marasà M, et al. Nat Rev Nephrol. 2009 Jun;5(6):337-48. doi: 10.1038/nrneph.2009.70. Nat Rev Nephrol. 2009. PMID: 19474828 Review.
The podocytopathies, including minimal-change nephropathy, focal segmental glomerulosclerosis, collapsing glomerulopathy, and diffuse mesangial sclerosis, involve diverse types of injury to podocytes. ...The data on all such therapies remain too fragmentary to provi …
The podocytopathies, including minimal-change nephropathy, focal segmental glomerulosclerosis, collapsing glomerulopathy, and …
CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases.
Obligado SH, Ibraghimov-Beskrovnaya O, Zuk A, Meijer L, Nelson PJ. Obligado SH, et al. Kidney Int. 2008 Mar;73(6):684-90. doi: 10.1038/sj.ki.5002731. Epub 2007 Dec 19. Kidney Int. 2008. PMID: 18094678 Free article. Review.
Preclinical efficacy has now been demonstrated in mesangial proliferative glomerulonephritis, crescentic glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, polycystic kidney diseases, diabetic nephropathy, and several forms of acute kidney …
Preclinical efficacy has now been demonstrated in mesangial proliferative glomerulonephritis, crescentic glomerulonephritis, collapsing …
50 results